Condition: Acute Lymphoblastic Leukemia, Pediatric · Sponsor: Roswell Park Cancer Institute
The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.
This description comes directly from the study's public registry record.
Elizabeth Bouchard, PhD · 716-845-1300 · Elizabeth.Bouchard@roswellpark.rog
Always discuss trial participation with your own doctor first.
| Roswell Park Comprehensive Cancer Center | Buffalo, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06074666